High Intensity Health - High LDL But NO Plaque Progression: Shocking New Study
The study titled 'Plaque B gets Plaque, Apo B does not' from the Keto CTA trial examines the relationship between LDL cholesterol and arterial plaque progression in metabolically healthy individuals. Over a year, 100 participants with high LDL and Apo B levels were monitored. The findings revealed no correlation between these lipid levels and plaque progression. Instead, the presence of pre-existing plaque was the primary predictor of further plaque development. This challenges the traditional view that high LDL is a direct cause of heart disease, suggesting that metabolic health and existing plaque are more significant factors.
The study highlights that individuals with high LDL but who are lean and metabolically healthy do not necessarily experience increased plaque progression. Factors such as insulin resistance, hypertension, and sleep-disordered breathing may influence LDL's role in plaque development. The research suggests focusing on overall metabolic health rather than solely on LDL levels. This perspective encourages a more nuanced approach to cardiovascular risk assessment, emphasizing lifestyle factors like diet, exercise, and stress management.
Key Points:
- High LDL cholesterol in metabolically healthy individuals does not predict plaque progression.
- Pre-existing plaque is the main predictor of further plaque development.
- Metabolic health factors like insulin resistance and hypertension influence LDL's impact.
- Lifestyle changes can optimize metabolic health and reduce cardiovascular risk.
- The study challenges traditional views on LDL and heart disease, suggesting a nuanced approach.
Details:
1. 🔬 Introduction to the Plaque Study
- The study, titled 'Plaque B gets Plaque, Apo B does not,' utilizes longitudinal data from the Keto CTA trial to explore the effects of high LDL cholesterol in metabolically healthy individuals.
- Key finding: High LDL cholesterol does not lead to increased arterial plaque progression in this demographic.
- The study challenges the traditional view that LDL cholesterol is a direct contributor to plaque buildup, highlighting the importance of metabolic health in cardiovascular risk assessment.
- Methodology: The study analyzed data over a specified period to assess changes in arterial plaque among participants with varying levels of LDL cholesterol.
- Implications: The outcomes suggest that focusing on metabolic health might be more critical than solely targeting LDL levels in preventing cardiovascular diseases.
2. 📈 Key Findings from the Keto CTA Trial
- Lean mass hyperresponders are characterized by high LDL cholesterol, high HDL cholesterol, and low blood triglycerides, indicating a unique lipid profile.
- These individuals are typically metabolically healthy and lean, challenging traditional views on cholesterol levels and heart health.
- The anecdotal evidence since 2016 highlights a consistent pattern among lean mass hyperresponders, suggesting the need for further clinical research to understand the implications.
- Understanding the metabolic health of these individuals could lead to more personalized dietary and health recommendations, especially for those on ketogenic diets.
3. 🧪 Year-long Study on Cholesterol and Arteries
- The study tracked 100 individuals over one year to examine the correlation between coronary artery atherosclerosis progression and APOB levels, using coronary CT angiograms for measurement.
- Findings revealed no correlation between the progression of coronary artery atherosclerosis and APOB levels, suggesting that other factors may contribute to plaque development in coronary arteries.
- These findings challenge the mainstream medical perspective on the role of LDL levels in coronary artery disease, indicating a need for a revised understanding of how LDL contributes to the disease, particularly in contexts of elevated LDL.
- Medical professionals are advised to consider the broader context of cardiovascular risk factors beyond apo-containing lipoproteins.
4. 🩺 HDL, LDL, and Metabolic Health
- In a cohort of 100 lean and metabolically healthy individuals, the mean LDL concentration was 254 mg/dL, which is considered high, and the mean apo B concentration was 185 mg/dL, also classified as high.
- Despite these high levels, the mean HDL level was a healthy 89 mg/dL, and triglycerides were low at 67 mg/dL, indicating a favorable lipid profile.
- The data suggests that even with high LDL and apo B levels, the individuals maintained good metabolic health, potentially due to other compensating factors such as high HDL and low triglycerides.
- This finding highlights the complexity of lipid management and the importance of looking at the entire lipid profile rather than focusing solely on LDL or apo B levels.
5. 🥩 Maui Nui Venison: A Nutrient-dense Sponsor
- Maui Nui Venison offers venison sticks that are nutrient-dense, containing glandular and organ meats such as heart, kidney, and liver along with wild-harvested venison.
- These venison products are marketed as superior to typical airport or convenience store foods in terms of taste and nutritional value.
- The venison is 100% wild-harvested from axis deer on the island of Maui, Hawaii, emphasizing sustainable and stress-free practices.
- Customers can purchase these products through the Maui Nui Venison website for potential savings and convenience.
6. 📊 Expert Analysis: Understanding Cholesterol
- A recent one-year perspective study examined individuals with extremely high LDL cholesterol levels, measuring 185 mg/dL for APOB and 254 mg/dL for LDL, to evaluate their impact on coronary artery progression.
- Traditional medical guidance suggests using statins and PCSK9 inhibitors to manage such high cholesterol levels, indicating the importance of these findings.
- The study uniquely identified that only the presence of existing plaque at the study's onset predicted coronary artery progression, challenging the direct correlation between LDL cholesterol levels and plaque development.
- These findings highlight a potential shift in treatment strategies, emphasizing the need for personalized medical approaches rather than a one-size-fits-all model based on LDL cholesterol levels alone.
7. 🔍 Factors in Plaque Development
- A regression in coronary artery CT andogram plaque score was observed, suggesting potential for plaque reduction.
- Research shows that in lean and metabolically healthy individuals, LDL or APOB concentrations are not reliable predictors of coronary artery plaque progression.
- The presence of existing plaque is a more significant factor in predicting plaque progression than LDL/APOB levels.
- Key contributors to plaque development may include oxidation of LDL, sleep disordered breathing, insulin resistance, undiagnosed hypertension, and increased blood viscosity.
- It is recommended to monitor morning blood pressure using specific apps to track potential plaque contributors.
8. ⏱️ Insights into Plaque Accumulation
- Pre-existing plaque is a significant predictor of future plaque accumulation over a year.
- Individuals with pre-existing plaque are more likely to develop additional plaque over time.
- The study highlights the importance of identifying individuals with existing plaque to understand the reasons behind their increased coronary artery plaque.
- High levels of LDL and APOB were not independently associated with plaque accumulation, suggesting other contributing factors.
- The research involved a cohort of 80 individuals, focusing on those fitting the lean mass hyperresponder phenotype, characterized by low triglycerides and high HDL.
- The study utilized a cohort method, analyzing participants over a year to determine predictors of plaque buildup.
- The findings underscore the need for targeted interventions in individuals with pre-existing plaque to mitigate further accumulation and associated cardiovascular risks.
9. 🧬 Metabolic Environment's Role in Heart Health
- Baseline coronary artery calcium score is the strongest independent factor predicting increased plaque accumulation over a one-year perspective study. This highlights the importance of initial calcium scoring in assessing future heart disease risk.
- LDL and Apolipoprotein B (Apo B) are independently and causally associated with heart disease and plaque accumulation, indicating that managing these levels is crucial for heart health.
- LDL is vital for transporting co-enzyme Q10, vitamin K, fat-soluble vitamins, nutrients, and cholesterol, all necessary for hormone production and cell membrane formation. This underscores the balance needed between lowering LDL for heart health and maintaining essential nutrient transport.
- The metabolic environment, influenced by factors like insulin resistance and high levels of certain markers, significantly impacts heart health and plaque accumulation. This suggests that addressing metabolic health can be as crucial as managing LDL levels.
- Real-world example: Studies have shown that interventions targeting insulin resistance can lead to a reduction in plaque accumulation, emphasizing the multifaceted approach needed for heart health.
10. 🚶♂️ Optimizing Lifestyle for Better Health
- Individuals with low visceral and body fat and optimal metabolic health may not have LDL that predisposes to atherosclerotic plaque formation.
- LDL's potential to cause atherosclerosis can be assessed quantitatively using coronary artery CT angiogram.
- Factors like insulin resistance, hypertension, and sleep-disordered breathing can make LDL more atherogenic.
- Focus should be on assessing insulin resistance in the context of LDL levels.
- Lean mass hyperresponders have specific lipid profiles: LDL > 190 mg/dL, HDL > 80 mg/dL, triglycerides < 80 mg/dL, with a median BMI of 22.5.
- Implementing lifestyle changes such as regular physical activity, a balanced diet, and proper sleep can help manage LDL levels and reduce insulin resistance.
- Practical steps include reducing carbohydrate intake, increasing fiber, and incorporating healthy fats to improve lipid profiles and metabolic health.
11. 🧠 The Importance of Personalized Medicine
- Six participants experienced a decrease in total plaque score over a year, indicating potential benefits of personalized approaches.
- Age is a major risk factor for coronary artery disease and heart attacks, with plaque accumulation increasing with age.
- The change in plaque volume was 8%, emphasizing that disease progression occurs over time.
- There was no independent association between coronary artery plaque changes over time and apo or LDL levels.
- The key takeaway is the need to optimize metabolic health to combat disease progression.
- Personalized medicine aims to tailor treatment based on individual characteristics, which can lead to better management of coronary artery disease.
- Understanding the individual's metabolic health is crucial for effective personalized treatments.
- The study suggests that personalized medicine could potentially reduce or stabilize plaque accumulation, a crucial factor in heart health.
12. 🩸 Tailoring Health Decisions to Individual Context
- Walking 10 to 12,000 steps per day is recommended for improving metabolic health. Prioritizing daily physical activity can significantly enhance overall well-being.
- Maintaining a consistent sleep schedule can aid in stress reduction and overall health, emphasizing the importance of regular sleep patterns.
- Avoiding processed carbohydrates, junk food, and sugar-sweetened beverages can prevent increases in blood glucose, insulin, and triglycerides. This dietary change is crucial for maintaining stable metabolic health.
- Prioritizing protein intake, consuming healthy fats, and following an omnivorous diet can optimize metabolic health and potentially lower the risk of coronary artery calcification and plaque accumulation. This approach highlights the benefits of balanced nutrition.
- The study highlighted in the video suggests that people on low-carb diets can be metabolically healthy even if their HDL and LDL cholesterol levels are high. This finding indicates the potential metabolic benefits of low-carb diets despite traditional cholesterol concerns.
13. 💡 Embracing Precision in Medicine
- Mainstream medicine often follows a protocol-driven approach, such as prescribing medication based on specific metrics like high LDL or glucose levels, which may not always consider the broader context of the patient's health.
- Patients often report feeling improvements in their well-being following lifestyle changes, which raises questions about the necessity of medication if they feel good despite certain high metrics.
- Healthcare providers face challenges in personalizing care due to administrative burdens, such as insurance and Medicare documentation, which can limit the time available to address individual patient nuances.
14. 📝 Final Thoughts and Acknowledgments
- Understanding lab results requires context, especially in precision and personalized medicine, which emphasizes factors like metabolic health, HDL, triglycerides, body fat percentage, and BMI. For instance, high LDL levels paired with insulin resistance and high body fat can increase the risk of problematic LDL leading to plaque formation.
- Acknowledgments were made to researchers such as Nick Norwitz, Dave Felman, and Matthew Budof for their contributions to the study 'Plaque Begets Plaque, ApoB Does Not,' which utilized longitudinal data from the Keto CTA trial, highlighting its significance in understanding plaque formation.